Daruka Mahadevan
The University of Texas MD Anderson Cancer Center
ORCID: 0000-0002-7129-5593Also affiliated with The University of Texas at San Antonio Health Science Center, The University of Texas Health Science Center at Houston
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 4 papers. Top paper: “First in human phase 1 study of DT2216, a selective BCL-xL degrader, in patients with relapsed/refractory solid malignancies”.
Minal Barve, Devalingam Mahalingam, Jay Parekh, Michael R. Kurman, James Strauss +10 more
Meizhen Chen, Daniel T. DeArmond, Cheryl Hsiang-Ling Chiu, Catherine A. Limboy, Xi Tan +19 more
Bárbara de la Peña Avalos, Jonathan Dao, Sebastian Montagnino, Dmytro Kovalskyy, Eloïse Dray +2 more
Eric S. Christenson, Davendra Sohal, S. Manda, Siqing Fu, A. Martz +13 more